Abstract:The growing use of molecular imaging helps to control and monitor dosage for increased safety and effectiveness. Molecular imaging agents become the scientific tools for moving a concept from bench work to clinic product development. This special issue provides original research and review of new trends in molecular imaging agent development. Among clinic molecular imaging modalities, radionuclide imaging technique is the most sensitive and could provide target-specific information. The radiotracer could non-invasively assess disease treatment endpoints which used to rely almost exclusively on biopsies and histopathological assays. L.-H. Shen et al. (Taiwan) reviewed molecular imaging in the diagnosis and management of CNS disorders. F.-L. Kong et al. (USA), N. Tsao et al. (USA), and C.-L. Ho et al. (Taiwan) report pharmacokinetics and dosimetry of molecular imaging compounds in oncology. M.-H. Liao et al. (Taiwan), X. Wang et al. (China), C. Wu et al. (China) and M. Tian et al. (USA) reported that molecular imaging techniques play a major role in the development of novel therapies since they measure target expressions (apoptosis, glycolysis) as well as function, pathway activities, and cell migration in the intact organism. Y.-F. Wang et al. and M.-Y. Chao et al. (Taiwan) described the kit probe for 99mTc-labeling which is crucial for centralized drug process. The kit probe may allow theranostic concept. A theranostic agent would be more accurate in the evaluation of patient response to treatment. The radiotracer could also be used for radionuclide therapy as reported by C. Wang et al. (China). Hybrid molecular imaging modalities (PET/CT, SPECT/CT) provide high-sensitivity functional and high-resolution anatomical imaging which are important in design-personalized treatment. M.-C. Chen et al. (Taiwan) reported the value of using I-131 NP-59 SPECT/CT to diagnose patients with subclinical or atypical features of primary aldosteronism. To proof of concept for molecular biology findings using different imaging modalities (optical, sonography) were described by Z. Pu et al. (China). In summary, molecular imaging enables the comprehensive characterization of therapeutic intervention and can be used in preclinical studies, pharmacokinetic studies, dose-finding studies, and proof-of-concept studies. Molecular imaging technologies promote the discovery and development of personalized medicine. Hong Zhang Mei Tian Carrio Ignasi Zhen Cheng Lie-Hang Shen David J. Yang

Label-Free Chemically and Molecularly Selective Magnetic Resonance Imaging.

Molecularly Targeted Magnetic Resonance Imaging and Spectroscopy

High-Resolution Label-Free Molecular Imaging of Brain Tumor.

Repurposing Clinical Agents for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging: Current Status and Future Perspectives

Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging

The role of responsive MRI probes in the past and the future of molecular imaging

Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications

Advances of Functional Nanomaterials for Magnetic Resonance Imaging and Biomedical Engineering Applications.

Review of a New Molecular Imaging Method——Deuterium Metabolic Spectroscopy and Imaging

Using optimal controlled singlet spin order to accurately target molecular signal in MRI and MRS

Molecular Image-Guided Theranostic and Personalized Medicine 2013

Molecular imaging: design mechanism and bioapplications

Artificially Engineered Nanoprobes for Ultrasensitive Magnetic Resonance Imaging.

Stimuli-responsive 19F MRI Probes: from Materials Design to in Vitro Detection and in Vivo Diagnosis

Multicolor 19F Magnetic Resonance Imaging: A Promising Medical Technique for in Vivo Visualization of Multiple Biological Targets

Research progress in molecular magnetic resonance imaging

Small is Smarter: Nano MRI Contrast Agents – Advantages and Recent Achievements

Engineering a Dual-Receptor Targeted Multivalent Probe for Enhanced Magnetic Resonance Imaging of Metastatic Cancer

Magnetic-susceptibility-dependent ratiometric probes for enhancing quantitative MRI

Progress on Multi-Modality Molecular Imaging

Magnetic Resonance Molecular Imaging in Cancer Research